Tr. Degrado et al., Synthesis and preliminary evaluation of F-18-labeled 4-thia palmitate as aPET tracer of myocardial fatty acid oxidation, NUCL MED BI, 27(3), 2000, pp. 221-231
Interest remains strong for the development of a noninvasive technique for
assessment of regional fatty acid oxidation rate in the myocardium. F-18-la
beled 4-thia palmitate (FTP, 16-[F-18]fluoro-4-thia-hexadecanoic acid) has
been synthesized and preliminarily evaluated as a metabolically trapped pro
be of myocardial fatty acid oxidation for positron emission tomography (PET
). The radiotracer is synthesized by Kryptofix 2.2.2/K2CO3 assisted nucleop
hilic radiofiuorination of an iodo-ester precursor, followed by alkaline hy
drolysis and by purification by reverse phase high performance liquid chrom
atography. Biodistribution studies in rats showed high uptake and long rete
ntion of FTP in heart, liver, and kidneys consistent with relatively high f
atty acid oxidation rates in these tissues. Inhibition of carnitine palmito
yl-transferase-I caused an 80% reduction in myocardial uptake, suggesting t
he dependence of trapping on the transport of tracer into the mitochondrion
. Experiments with perfused rat hearts showed that the estimates of the fra
ctional metabolic trapping rate (FR) of FTP tracked inhibition of oxidation
rate of palmitate with hypoxia, whereas the FR of the 6-thia analog 17-[F-
18]fluoro-6-thia-heptadecanoic acid was insensitive to hypoxia. In vivo def
luorination of FTP in the rat was evidenced by bone uptake of radioactivity
. A PET imaging study with FTP in normal swine showed excellent myocardial
images, prolonged myocardial retention, and no bone uptake of radioactivity
up to 3 h, the last finding suggesting a species dependence for defluorina
tion of the omega-labeled fatty acid. The results support further investiga
tion of FTP as a potential PET tracer for assessing regional fatty acid oxi
dation rate in the human myocardium. NUCL MED BIOL 27;3:221-231, 2000. (C)
2000 Elsevier Science Inc. All rights reserved.